From the Department of Neurological Surgery, University of Virginia Health System, Charlottesville (C.-J.C., J.P.S.).
Department of Neurosurgery, University of Louisville, KY (D.D.).
Stroke. 2018 Aug;49(8):1939-1945. doi: 10.1161/STROKEAHA.118.022052.
Background and Purpose- The aim of this international, multicenter, retrospective matched cohort study is to directly compare the outcomes after stereotactic radiosurgery (SRS) for brain arteriovenous malformations (AVM) in pediatric versus adult patients. Methods- We performed a retrospective review of patients with AVM who underwent SRS at 8 institutions participating in the International Gamma Knife Research Foundation from 1987 to 2014. Patients were categorized into pediatric (<18 years of age) and adult (≥18 years of age) cohorts and matched in a 1:1 ratio using propensity scores. Favorable outcome was defined as AVM obliteration, no post-SRS hemorrhage, and no permanently symptomatic radiation-induced changes. Results- From a total of 2191 patients who were eligible for inclusion in the overall study cohort, 315 were selected for each of the matched cohorts. There were no significant differences between matched pediatric versus adult cohorts with respect to the rates of favorable outcome (59% versus 58%; P=0.936), AVM obliteration (62% versus 63%; P=0.934), post-SRS hemorrhage (9% versus 7%; P=0.298), radiological radiation-induced changes (26% versus 26%; P=0.837), symptomatic radiation-induced changes (7% versus 9%; P=0.383), or permanent radiation-induced changes (2% versus 3%; P=0.589). The all-cause mortality rate was significantly lower in the matched pediatric cohort (3% versus 10%; P=0.003). Conclusions- The outcomes after SRS for comparable AVMs in pediatric versus adult patients were not found to be appreciably different. SRS remains a reasonable treatment option for appropriately selected pediatric patients with AVM, who harbor a high cumulative lifetime hemorrhage risk. Age seems to be a poor predictor of AVM outcomes after SRS.
背景与目的-本项国际性、多中心、回顾性匹配队列研究旨在直接比较儿童与成人接受立体定向放射外科(SRS)治疗脑动静脉畸形(AVM)的疗效。方法-我们对自 1987 年至 2014 年期间参与国际伽玛刀研究基金会的 8 个机构中接受 SRS 治疗的 AVM 患者进行了回顾性研究。患者被分为儿童(<18 岁)和成人(≥18 岁)队列,并使用倾向评分进行 1:1 匹配。良好的转归定义为 AVM 闭塞、无 SRS 后出血以及无永久性症状性放射性诱导改变。结果-在总共 2191 名符合总体研究队列纳入标准的患者中,每组有 315 名患者被纳入匹配队列。在良好转归率(59%比 58%;P=0.936)、AVM 闭塞率(62%比 63%;P=0.934)、SRS 后出血率(9%比 7%;P=0.298)、放射性诱导改变的影像学表现率(26%比 26%;P=0.837)、症状性放射性诱导改变率(7%比 9%;P=0.383)或永久性放射性诱导改变率(2%比 3%;P=0.589)方面,匹配的儿童与成人队列之间无显著差异。在匹配的儿童队列中,全因死亡率明显较低(3%比 10%;P=0.003)。结论-在接受 SRS 治疗的相似 AVM 患者中,儿童与成人之间的疗效并无明显差异。对于具有较高终生出血风险的适当选择的儿童患者,SRS 仍然是一种合理的治疗选择。年龄似乎不能很好地预测 SRS 治疗后 AVM 的转归。